About Progeroid features-hepatocellular carcinoma predisposition syndrome
Progeroid features-hepatocellular carcinoma predisposition syndrome is a rare disease catalogued by Orphanet (ORPHA:435953). It is associated with the SPRTN gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Progeroid features-hepatocellular carcinoma predisposition syndrome trials.
Search ClinicalTrials.gov for "Progeroid features-hepatocellular carcinoma predisposition syndrome" or filter by Orphanet code ORPHA:435953 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Progeroid features-hepatocellular carcinoma predisposition syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Progeroid features-hepatocellular carcinoma predisposition syndrome. Updated daily.